Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Spironolactone effectively treats female pattern hair loss with few side effects.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Review finds no permanent solution for female hair loss.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Some breast cancer chemotherapy can cause permanent hair loss.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.